Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2013-11-14Clinical Trial Update: A Phase-II Trial of ZIO 101 in Advanced Hepatocellular Carcinoma [Phase 2]
This document provides an update on a Phase II trial of ZIO 101 for advanced hepatocellular carcinoma, sponsored by Alaunos Therapeutics, wi…
-
CLINICAL_TRIALS research · 2013-11-14Clinical Trial Update: Circulating Tumor Cells for Hepatocellular Carcinoma
An update on a clinical trial investigating circulating tumor cells as a biomarker in hepatocellular carcinoma; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2013-11-13Clinical Trial Update: Methylprednisolone N Acetylcysteine in Hepatic Resections [Phase 2]
Phase 2 trial evaluating methylprednisolone combined with N-acetylcysteine in hepatic resection was terminated.
-
CLINICAL_TRIALS trial_result · 2013-11-07Clinical Trial Update: Immunotherapy of Hepatocellular Carcinoma by Induction of Anti-alpha Fetoprotein Response [Phase 1, Phase 2]
Phase 1/Phase 2 immunotherapy trial for hepatocellular carcinoma aiming to induce an anti-alpha fetoprotein response was terminated.
-
CLINICAL_TRIALS trial_result · 2013-10-31Clinical Trial Update: Hepatocellular Carcinoma - Advanced Stage - Sorafenib Trial in Taiwanese Patients [Phase 4]
Phase 4 trial of sorafenib in Taiwanese patients with advanced hepatocellular carcinoma has been completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-10-28Clinical Trial Update: Characterization of Baseline Biomarker Variability in Participants With Hepatocellular Carcinoma (MK-0000-215) [Phase 1]
Phase 1 study MK-0000-215 characterizes baseline biomarker variability in participants with hepatocellular carcinoma; the trial was terminat…
-
CLINICAL_TRIALS research · 2013-10-25Clinical Trial Update: PET Scan as a Screening Tool for Liver Transplant in Patients With Hepatocellular Carcinoma (HCC) [NA]
This clinical trial update reports a completed study evaluating PET scanning as a screening tool for liver transplant eligibility in patient…
-
CLINICAL_TRIALS trial_result · 2013-10-21Clinical Trial Update: Intraoperative Cell Saver Autotransfusion Use for Major Surgical Oncology Operations.
This is a completed clinical trial update evaluating intraoperative cell saver autotransfusion during major surgical oncology operations. Th…
-
CLINICAL_TRIALS trial_result · 2013-10-17Clinical Trial Update: Cisplatin or Carboplatin and Sorafenib in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery [Phase 2]
Phase 2 trial evaluating cisplatin or carboplatin in combination with sorafenib for unresectable liver cancer has completed and posted resul…
-
FDA approval · 2013-10-16FDA Approved: EOVIST — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
The FDA has approved Bayer's supplemental application for Eovist (gadoxetate disodium), updating its labeling to expand its use as an MRI co…
-
CLINICAL_TRIALS trial_result · 2013-10-14Clinical Trial Update: MRI of the Liver With Eovist
This clinical trial update notes the termination of a study evaluating Eovist for MRI of the liver in hepatocellular carcinoma.
-
CLINICAL_TRIALS research · 2013-10-08Clinical Trial Update: The Follow-up Study of Chronic Hepatitis B Patients With Liver Cirrhosis Receiving Anti-HBV Therapy
A follow-up study of chronic hepatitis B infection with liver cirrhosis receiving anti-HBV therapy; the document does not provide study resu…
-
CLINICAL_TRIALS trial_result · 2013-10-01Clinical Trial Update: Recurrence of Hepatocellular Carcinoma
A clinical trial investigating hepatocellular carcinoma has completed; the update concerns recurrence.
-
CLINICAL_TRIALS trial_result · 2013-10-01Clinical Trial Update: Procalcitonin in Hepatocellular Carcinoma
A completed clinical trial at Ain Shams University investigated procalcitonin in hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: Nexavar-Tarceva Combination Therapy for First Line Treatment of Patients Diagnosed With Hepatocellular Carcinoma [Phase 3]
Phase 3 trial update on Nexavar-Tarceva combination as first-line therapy for hepatocellular carcinoma has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2013-09-20Clinical Trial Update: Radioactive Iodine in Treating Patients Who Have Undergone Surgery for Liver Cancer [Phase 3]
A Phase 3 clinical trial evaluating radioactive iodine therapy after surgery for liver cancer; current status is not disclosed.
-
CLINICAL_TRIALS trial_result · 2013-09-16Clinical Trial Update: Sorafenib With BIIB022 in Hepatocellular Carcinoma (HCC) [Phase 1]
The document reports the completion of a Phase 1 study evaluating the combination of sorafenib and BIIB022 in hepatocellular carcinoma.
-
FDA approval · 2013-09-13FDA Approved: STIVARGA — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
FDA approved a supplemental application for Stivarga (regorafenib) submitted by Bayer HealthCare Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2013-09-09Clinical Trial Update: Single Center Experience Over a Decade in Living Donor Liver Transplantation for Egyptian Patients With Hepatocellular Carcinoma: Stretching the Limits
This completed, single-center study from Ain Shams University analyzes outcomes of living donor liver transplantation in Egyptian patients w…
-
CLINICAL_TRIALS trial_result · 2013-09-06Clinical Trial Update: Assessing BAY86-9766 Plus Sorafenib for the Treatment of Liver Cancer. [Phase 2]
A Phase 2 trial evaluating BAY 86-9766 in combination with sorafenib for hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS withdrawal · 2013-09-05Clinical Trial Update: Radiation Therapy With Sorafenib for TACE-Resistant Hepatocellular Carcinoma [Phase 1]
Phase 1 trial evaluating radiation therapy with sorafenib for hepatocellular carcinoma resistant to transarterial chemoembolization has been…
-
CLINICAL_TRIALS trial_result · 2013-09-04Clinical Trial Update: Urea Cream Treatment Sorafenib-Associated HSFR in HCC [Phase 2]
Phase 2 trial evaluating topical urea cream to treat sorafenib-associated hand-foot skin reaction in hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-08-23Clinical Trial Update: Randomized Phase 1/2 Open-Label Trial of PR104 and Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC) [Phase 1, Phase 2]
A randomized Phase 1/2 open-label trial evaluating PR-104 in combination with sorafenib in patients with advanced hepatocellular carcinoma; …
-
CLINICAL_TRIALS research · 2013-08-19Clinical Trial Update: National Registry and Blood Bank of Patients With Liver Cancer
This ClinicalTrials.gov update describes a completed nationwide registry and blood bank study of patients with hepatocellular carcinoma.
-
CLINICAL_TRIALS other · 2013-08-16Clinical Trial Update: Adjuvant Therapy With Thalidomide After Curative Resection of Hepatocellular Carcinoma [NA]
This clinical trial update discusses adjuvant thalidomide after curative resection of hepatocellular carcinoma; the current status of the tr…